Aptus Endosystems

Headquartered in Sunnyvale, CA, Aptus Endosystems is a privately held medical device company engaged in developing & manufacturing advanced technology for endovascular aneurysm repair (EVAR). An estimated 1.5 million Americans have an abdominal aortic aneurysm (AAA), which can be life-threatening if left untreated. Approximately 200,000 people are newly diagnosed each year. Open surgical repair of aortic aneurysms, a treatment option practiced for decades, has high procedure related mortality rates & long patient recovery times. However, open surgical repair provides patients with a durable treatment requiring little to no follow-up or need for re-interventions. EVAR, which has been in practice since the 1990’s, is a minimally invasive catheter based AAA treatment with significantly reduced procedure related mortality & patient recovery time- but requires annual monitoring and may need additional interventions in the years after treatment. We are focused on developing innovative technologies to transform EVAR, empowering physicians to perform minimally invasive aneurysm repair while still providing the control & potential long term durability of open surgery. Our initial product offering is an innovative helical anchor technology—the Heli-FX EndoAnchor System (commercially available in the US & EU). The advent of our EndoAnchor System pioneers a new endovascular capability with potential applications beyond AAA repair. System Components: Heli-FX Guide ▪ Different deflected tip reach lengths address varying neck diameters ▪ Radiopaque tip markers provide 3D orientation of guide tip Heli-FX Applier ▪ Two-stage EndoAnchor deployment allows placement confirmation and repositioning ▪ EndoAnchor Cassette with 10 EndoAnchors packaged in sterile cassette Ancillary EndoAnchor Cassette ▪ Provides an additional 5 EndoAnchors packaged in a sterile cassette ▪ Addresses needs of more complex procedures, which require greater than 10 EndoAnchors